Literature DB >> 6822746

Amphotericin B tolerance: a characteristic of Candida parapsilosis not shared by other Candida species.

S M Seidenfeld, B H Cooper, J W Smith, J P Luby, P A Mackowiak.   

Abstract

Thirty yeast isolates from clinical specimens were tested for their susceptibility to amphotericin B at 30 C, 37 C, and 39 C. Of the six Candida albicans, five Candida tropicalis, one Candida guilliermondii, one Candida krusei, one Candida pseudotropicalis, two Torulopsis glabrata, and four Cryptococcus neoformans isolates tested, all were inhibited at amphotericin B concentrations of less than or equal to 0.4 micrograms/ml and killed by concentrations of amphotericin B that were less than or equal to 16-fold higher than the minimal inhibitory concentration (MIC). Although growth of Candida parapsilosis was also inhibited by concentrations of amphotericin B of less than or equal to 0.4 micrograms/ml, minimal fungicidal concentrations of amphotericin B were greater than or equal to 32-fold higher than MICs for each of the 10 isolates examined. This unique susceptibility pattern of C. parapsilosis resembles the antibiotic tolerance observed with Staphylococcus aureus. Variations in temperature within the experimental range did not affect the amphotericin B susceptibility for any of the yeasts examined.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822746     DOI: 10.1093/infdis/147.1.116

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Systemic antifungal agents.

Authors:  L O Gentry
Journal:  Tex Heart Inst J       Date:  1990

3.  Efficacy of LY303366 against amphotericin B-susceptible and -resistant Aspergillus fumigatus in a murine model of invasive aspergillosis.

Authors:  P E Verweij; K L Oakley; J Morrissey; G Morrissey; D W Denning
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

4.  Outbreak of Candida parapsilosis fungemia in neonatal intensive care units: clinical implications and genotyping analysis.

Authors:  Y C Huang; T Y Lin; H S Leu; H L Peng; J H Wu; H Y Chang
Journal:  Infection       Date:  1999 Mar-Apr       Impact factor: 3.553

5.  Identification of Candida parapsilosis Sensu Lato in Pediatric Patients and Antifungal Susceptibility Testing.

Authors:  Maria Emilia Cattana; Catiana Dudiuk; Mariana Fernández; Florencia Rojas; Liliana Alegre; Susana Córdoba; Guillermo Garcia-Effron; Gustavo Giusiano
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 6.  Candida parapsilosis: from Genes to the Bedside.

Authors:  Renáta Tóth; Jozef Nosek; Héctor M Mora-Montes; Toni Gabaldon; Joseph M Bliss; Joshua D Nosanchuk; Siobhán A Turner; Geraldine Butler; Csaba Vágvölgyi; Attila Gácser
Journal:  Clin Microbiol Rev       Date:  2019-02-27       Impact factor: 26.132

7.  Trichosporon beigelii, an emerging pathogen resistant to amphotericin B.

Authors:  T J Walsh; G P Melcher; M G Rinaldi; J Lecciones; D A McGough; P Kelly; J Lee; D Callender; M Rubin; P A Pizzo
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

Review 8.  Candidiasis.

Authors:  F Meunier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

9.  Management of deep Candida infection in surgical and intensive care unit patients. British Society for Antimicrobial Chemotherapy Working Party.

Authors: 
Journal:  Intensive Care Med       Date:  1994-08       Impact factor: 17.440

10.  Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.

Authors:  A L Colombo; D A McGough; M G Rinaldi
Journal:  Mycopathologia       Date:  1994-12       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.